PRA1 co-localizes with envelope but does not influence primate lentivirus production, infectivity or envelope incorporation

J Gen Virol. 2005 Jun;86(Pt 6):1785-1790. doi: 10.1099/vir.0.80873-0.

Abstract

The results of yeast and mammalian two-hybrid assays previously indicated complex formation between prenylated Rab acceptor 1 (PRA1) and the cytoplasmic domain of gp41 (gp41CD) for both the human and simian immunodeficiency viruses [Evans, D. T., Tilman, K. C. & Desrosiers, R. C. (2002). J Virol 76, 327-337]. The assembly and release of infectious virus particles was studied under conditions of PRA1 overexpression in a transient transfection assay or suppression by RNA interference. Although a clear pattern of co-localization of PRA1 and gp41 was observed, no changes in virion release, infectivity or envelope content were observed as a result of either PRA1 suppression or overexpression. These data show that PRA1 co-localizes with gp41 inside cells and they are consistent with a direct or indirect interaction between these proteins. However, variation in the levels of PRA1 expression did not influence virion production, infectivity or envelope incorporation under the conditions of these assays.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Carrier Proteins / metabolism*
  • GTP-Binding Proteins
  • HIV Envelope Protein gp41 / metabolism*
  • Humans
  • Membrane Glycoproteins / metabolism*
  • Membrane Proteins
  • Retroviridae Proteins / metabolism*
  • Simian Immunodeficiency Virus / pathogenicity*
  • Simian Immunodeficiency Virus / physiology*
  • Vesicular Transport Proteins
  • Virulence
  • Virus Replication

Substances

  • Carrier Proteins
  • HIV Envelope Protein gp41
  • Membrane Glycoproteins
  • Membrane Proteins
  • Retroviridae Proteins
  • SIV envelope protein gp41
  • Vesicular Transport Proteins
  • GTP-Binding Proteins
  • RABAC1 protein, human